Here are five notes:
1. The FDA approved the Triathlon total knee device last year.
2. Stryker plans to run clinical trials to study how surgeons use the robot-assisted surgery device so they can figure out a training protocol for surgeons who have little prior experience with robotics.
3. The company wants to avoid surgeon training issues it faced in the past.
4. Stryker bought Mako in 2013, in a $1.7 billion deal that CEO Kevin Lobo described as “messy.”
5. The company is planning to launch the Triathlon total knee in 2017.
More articles on devices:
Medovex to attend BritSpine 2016 conference: 6 notes
7 points on Implanet’s 2015 annual report
FDA clears Renovis’ 3-D printed cervical cage: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
